WHAT IS MOUNJARO® (TIRZEPATIDE) Like other well-known GLP-1 drugs—such as Wegovy—Mounjaro® is a once-weekly injectable medication. Clinical trials found doses of tirzepatide effective in reducing A1C levels and assisting with significant weight loss!
HOW DOES MOUNJARO® (TIRZEPATIDE) WORK?
Mounjaro® works similarly to the other drugs like Wegovy, but it contains an extra peptide that may give it a slight edge. The medication has a dual-action design, mimicking the action of not one but two peptides involved in blood sugar control: Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This unique dual action makes it the first-in-class medicine that acts on both of these receptors resulting in greater reductions in body weight, glucose control, and lipids!
MOUNJARO VS. WEGOVY FOR WEIGHT LOSS
IIs Mounjaro® really all that special? All signs point to YES!
Results of the drug’s clinical trials were making headlines even prior to its FDA approval, and for good reason: Tirzepatide has, in two separate studies, blown some of its competitors out of the water!
GET STARTED TODAY! SCHEDULE A COMPLIMENTARTY CONSULTATION!